Comments on
Janssen Launches Healthy Minds Initiative with $3 Million


Janssen Launches Healthy Minds Initiative with $3 MillionLast week, Janssen Pharmaceuticals announced an interesting partnership with the International Mental Health Research Organization (IMHRO) to support One Mind for Research with $3 million in funding. One Mind for Research a program of IMHRO that fosters neuroscience research, education, and awareness-building programs.

Janssen is the developer and manufacturer of a number of psychiatric medications, including Concerta, Invega, and Risperdal. Janssen is a division of Johnson & Johnson.

As part of the Healthy Minds efforts, Janssen will become the first private-sector partner to support the One Mind for Research program, which was started by former U.S. Congressman Patrick Kennedy and Garen Staglin, Vice President, Board of Directors, IMHRO.

Join the Conversation!

Before posting, please read our blog moderation guidelines.

Post a Comment:

(Required, will be published)

(Required, but will not be published)

(Optional)